The association of these clinical features with mutations in the DNAJB6 gene and the use of new sequencing technologies allowed the identification of novel mutations in more LGMD1D patients. This evidence concerns the gene DNAJB6 and autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6).